Lantheus Holdings, Inc.
For the period ended Sep 30, 2025. Filed Nov 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 6, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| INCORPORATED BY REFERENCE | |||||
| EXHIBITNUMBER | DESCRIPTION OF EXHIBITS | FORM | FILENUMBER | EXHIBIT | FILINGDATE |
|---|---|---|---|---|---|
| 10.1*# | Deed of Amendment and Restatement Relating to a Sale and Purchase Agreement entered into July 21, 2025, by and among Life Medical Group Limited and Life Healthcare Group Holdings Limited and Lantheus Radiopharmaceuticals UK Limited and Lantheus Medical Imaging. | ||||
| 31.1* | Certification of Chief Executive Officer pursuant to Exchange Act Rule 13a-14(a). | ||||
| 31.2* | Certification of Chief Financial Officer pursuant to Exchange Act Rule 13a-14(a). | ||||
| 32.1** | Certification pursuant to 18 U.S.C. Section 1350. | ||||
| 101.INS* | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | ||||
| 101.SCH* | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents | ||||
| 104* | Cover Page Interactive Data File (embedded within the Inline XBRL document) | ||||
- Filed herewith.
** Furnished herewith.
Pursuant to Item 601(b)(10)(iv) of Regulation S-K promulgated by the SEC, certain portions of this exhibit have been redacted because the Company customarily and actually treats such omitted information as private or confidential and because such omitted information is not material.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.